Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

ALAMEDA, Calif.--(BUSINESS WIRE)-- #CRISPR--Company will highlight developments enabled by its CRISPR by Design™ approach to engineer novel in vivo genetic medicines